Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 95
Filter
Add more filters

Publication year range
1.
FASEB J ; 37(11): e23229, 2023 11.
Article in English | MEDLINE | ID: mdl-37795915

ABSTRACT

Toxoplasma gondii is an obligate, intracellular apicomplexan protozoan parasite of both humans and animals that can cause fetal damage and abortion and severe disease in the immunosuppressed. Sphingolipids have indispensable functions as signaling molecules and are essential and ubiquitous components of eukaryotic membranes that are both synthesized and scavenged by the Apicomplexa. Ceramide is the precursor for all sphingolipids, and here we report the identification, localization and analyses of the Toxoplasma ceramide synthases TgCerS1 and TgCerS2. Interestingly, we observed that while TgCerS1 was a fully functional orthologue of the yeast ceramide synthase (Lag1p) capable of catalyzing the conversion of sphinganine to ceramide, in contrast TgCerS2 was catalytically inactive. Furthermore, genomic deletion of TgCerS1 using CRISPR/Cas-9 led to viable but slow-growing parasites indicating its importance but not indispensability. In contrast, genomic knock out of TgCerS2 was only accessible utilizing the rapamycin-inducible Cre recombinase system. Surprisingly, the results demonstrated that this "pseudo" ceramide synthase, TgCerS2, has a considerably greater role in parasite fitness than its catalytically active orthologue (TgCerS1). Phylogenetic analyses indicated that, as in humans and plants, the ceramide synthase isoforms found in Toxoplasma and other Apicomplexa may have arisen through gene duplication. However, in the Apicomplexa the duplicated copy is hypothesized to have subsequently evolved into a non-functional "pseudo" ceramide synthase. This arrangement is unique to the Apicomplexa and further illustrates the unusual biology that characterize these protozoan parasites.


Subject(s)
Parasites , Toxoplasma , Humans , Animals , Toxoplasma/genetics , Gene Duplication , Phylogeny , Sphingolipids , Ceramides/genetics , Protozoan Proteins/genetics
2.
PLoS Comput Biol ; 19(9): e1011511, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37769024

ABSTRACT

Computer programming is a fundamental tool for life scientists, allowing them to carry out essential research tasks. However, despite various educational efforts, learning to write code can be a challenging endeavor for students and researchers in life-sciences disciplines. Recent advances in artificial intelligence have made it possible to translate human-language prompts to functional code, raising questions about whether these technologies can aid (or replace) life scientists' efforts to write code. Using 184 programming exercises from an introductory-bioinformatics course, we evaluated the extent to which one such tool-OpenAI's ChatGPT-could successfully complete programming tasks. ChatGPT solved 139 (75.5%) of the exercises on its first attempt. For the remaining exercises, we provided natural-language feedback to the model, prompting it to try different approaches. Within 7 or fewer attempts, ChatGPT solved 179 (97.3%) of the exercises. These findings have implications for life-sciences education and research. Instructors may need to adapt their pedagogical approaches and assessment techniques to account for these new capabilities that are available to the general public. For some programming tasks, researchers may be able to work in collaboration with machine-learning models to produce functional code.

3.
PLoS Pathog ; 16(4): e1008464, 2020 04.
Article in English | MEDLINE | ID: mdl-32324805

ABSTRACT

Streptococcus pneumoniae is a major human pathogen, causing pneumonia and sepsis. Genetic components strongly influence host responses to pneumococcal infections, but the responsible loci are unknown. We have previously identified a locus on mouse chromosome 7 from a susceptible mouse strain, CBA/Ca, to be crucial for pneumococcal infection. Here we identify a responsible gene, Cd22, which carries a point mutation in the CBA/Ca strain, leading to loss of CD22 on B cells. CBA/Ca mice and gene-targeted CD22-deficient mice on a C57BL/6 background are both similarly susceptible to pneumococcal infection, as shown by bacterial replication in the lungs, high bacteremia and early death. After bacterial infections, CD22-deficient mice had strongly reduced B cell populations in the lung, including GM-CSF producing, IgM secreting innate response activator B cells, which are crucial for protection. This study provides striking evidence that CD22 is crucial for protection during invasive pneumococcal disease.


Subject(s)
B-Lymphocytes/immunology , Pneumococcal Infections/immunology , Sialic Acid Binding Ig-like Lectin 2/immunology , Animals , B-Lymphocytes/microbiology , Bacteremia/genetics , Bacteremia/immunology , Bacteremia/microbiology , Female , Host-Pathogen Interactions , Humans , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred CBA , Pneumococcal Infections/genetics , Pneumococcal Infections/metabolism , Pneumonia, Pneumococcal/genetics , Pneumonia, Pneumococcal/immunology , Pneumonia, Pneumococcal/metabolism , Pneumonia, Pneumococcal/microbiology , Sialic Acid Binding Ig-like Lectin 2/deficiency , Sialic Acid Binding Ig-like Lectin 2/genetics , Streptococcus pneumoniae/pathogenicity
4.
Nucleic Acids Res ; 47(D1): D786-D792, 2019 01 08.
Article in English | MEDLINE | ID: mdl-30304474

ABSTRACT

The HUGO Gene Nomenclature Committee (HGNC) based at EMBL's European Bioinformatics Institute (EMBL-EBI) assigns unique symbols and names to human genes. There are over 40 000 approved gene symbols in our current database of which over 19 000 are for protein-coding genes. The Vertebrate Gene Nomenclature Committee (VGNC) was established in 2016 to assign standardized nomenclature in line with human for vertebrate species that lack their own nomenclature committees. The VGNC initially assigned nomenclature for over 15000 protein-coding genes in chimpanzee. We have extended this process to other vertebrate species, naming over 14000 protein-coding genes in cow and dog and over 13 000 in horse to date. Our HGNC website https://www.genenames.org has undergone a major design update, simplifying the homepage to provide easy access to our search tools and making the site more mobile friendly. Our gene families pages are now known as 'gene groups' and have increased in number to over 1200, with nearly half of all named genes currently assigned to at least one gene group. This article provides an overview of our online data and resources, focusing on our work over the last two years.


Subject(s)
Computational Biology/standards , Databases, Genetic/standards , Genomics/standards , Terminology as Topic , Animals , Cattle , Dogs , Horses/genetics , Humans , Pan troglodytes/genetics , Search Engine
5.
Microb Pathog ; 147: 104406, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32738284

ABSTRACT

We focused on apoptotic blebs from Leishmania major-infected macrophages as a vaccine for cutaneous leishmaniasis. Apoptosis was induced in L. major-infected J774A.1 cells in order to prepare apoptotic blebs. Test groups of BALB/c mice were immunized with these at doses of 1 × 106, 5 × 106 or 1 × 107 blebs. An immunization control group received Leishmania lysate antigens. The results showed that as the number of apoptotic bodies increased, the lymphocyte proliferation index increased, and this was proportional to IFN-γ level in the test groups. Additionally, the difference of IFN-γ, IL-4, IFN-γ/IL-4 ratio, or total IgG (p < 0.0001) in all groups was statistically significant compared to the negative control group. The highest IFN-γ (514.0 ± 40.92 pg/mL) and IFN-γ/IL-4 ratio (2.94 ± 0.22) were observed in the group that received 1 × 107 apoptotic blebs. The highest levels of IL-4 (244.6 ± 38.8 pg/mL) and total IgG (5626 ± 377 µg/mL) were observed in the immunization control group. Reflecting these data, no lesions were observed in any of the groups vaccinated with apoptotic blebs after 12 weeks. In summary, the use of apoptotic blebs from L. major-infected macrophages is protective against the challenge with L. major in this animal model.


Subject(s)
Leishmania major , Leishmaniasis, Cutaneous , Leishmaniasis , Vaccination , Animals , Mice , Antigens, Protozoan , Cytokines , Leishmania major/pathogenicity , Leishmaniasis, Cutaneous/prevention & control , Macrophages , Mice, Inbred BALB C
6.
J Biol Chem ; 292(29): 12208-12219, 2017 07 21.
Article in English | MEDLINE | ID: mdl-28578314

ABSTRACT

Toxoplasma gondii is an obligate, intracellular eukaryotic apicomplexan protozoan parasite that can cause fetal damage and abortion in both animals and humans. Sphingolipids are essential and ubiquitous components of eukaryotic membranes that are both synthesized and scavenged by the Apicomplexa. Here we report the identification, isolation, and analyses of the Toxoplasma serine palmitoyltransferase, an enzyme catalyzing the first and rate-limiting step in sphingolipid biosynthesis: the condensation of serine and palmitoyl-CoA. In all eukaryotes analyzed to date, serine palmitoyltransferase is a highly conserved heterodimeric enzyme complex. However, biochemical and structural analyses demonstrated the apicomplexan orthologue to be a functional, homodimeric serine palmitoyltransferase localized to the endoplasmic reticulum. Furthermore, phylogenetic studies indicated that it was evolutionarily related to the prokaryotic serine palmitoyltransferase, identified in the Sphingomonadaceae as a soluble homodimeric enzyme. Therefore this enzyme, conserved throughout the Apicomplexa, is likely to have been obtained via lateral gene transfer from a prokaryote.


Subject(s)
Endoplasmic Reticulum/enzymology , Models, Molecular , Phylogeny , Protozoan Proteins/metabolism , Serine C-Palmitoyltransferase/metabolism , Toxoplasma/enzymology , Amino Acid Sequence , Catalytic Domain , Computational Biology , Conserved Sequence , Dimerization , Gene Deletion , Gene Duplication , Gene Transfer, Horizontal , Isoenzymes/chemistry , Isoenzymes/genetics , Isoenzymes/isolation & purification , Isoenzymes/metabolism , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/metabolism , Protein Conformation , Protein Interaction Domains and Motifs , Protein Transport , Protozoan Proteins/chemistry , Protozoan Proteins/genetics , Protozoan Proteins/isolation & purification , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Sequence Alignment , Serine C-Palmitoyltransferase/chemistry , Serine C-Palmitoyltransferase/genetics , Serine C-Palmitoyltransferase/isolation & purification , Structural Homology, Protein
7.
Article in English | MEDLINE | ID: mdl-29463533

ABSTRACT

With the World Health Organization reporting over 30,000 deaths and 200,000 to 400,000 new cases annually, visceral leishmaniasis is a serious disease affecting some of the world's poorest people. As drug resistance continues to rise, there is a huge unmet need to improve treatment. Miltefosine remains one of the main treatments for leishmaniasis, yet its mode of action (MoA) is still unknown. Understanding the MoA of this drug and parasite response to treatment could help pave the way for new and more successful treatments for leishmaniasis. A novel method has been devised to study the metabolome and lipidome of Leishmania donovani axenic amastigotes treated with miltefosine. Miltefosine caused a dramatic decrease in many membrane phospholipids (PLs), in addition to amino acid pools, while sphingolipids (SLs) and sterols increased. Leishmania major promastigotes devoid of SL biosynthesis through loss of the serine palmitoyl transferase gene (ΔLCB2) were 3-fold less sensitive to miltefosine than wild-type (WT) parasites. Changes in the metabolome and lipidome of miltefosine-treated L. major mirrored those of L. donovani A lack of SLs in the ΔLCB2 mutant was matched by substantial alterations in sterol content. Together, these data indicate that SLs and ergosterol are important for miltefosine sensitivity and, perhaps, MoA.


Subject(s)
Antiprotozoal Agents/pharmacology , Leishmania donovani/metabolism , Leishmania major/metabolism , Phosphorylcholine/analogs & derivatives , Serine C-Palmitoyltransferase/genetics , Sphingolipids/metabolism , Sterols/metabolism , Ergosterol/metabolism , Humans , Leishmaniasis, Visceral/drug therapy , Leishmaniasis, Visceral/parasitology , Membrane Lipids/metabolism , Metabolome/drug effects , Metabolome/genetics , Phospholipids/metabolism , Phosphorylcholine/pharmacology
8.
Parasitology ; 145(2): 111-115, 2018 02.
Article in English | MEDLINE | ID: mdl-29143719

ABSTRACT

The rise of antimicrobial resistance, coupled with a lack of industrial focus on antimicrobial discovery over preceding decades, has brought the world to a crisis point. With both human and animal health set to decline due to increased disease burdens caused by near untreatable microbial pathogens, there is an urgent need to identify new antimicrobials. Central to this is the elucidation of new, robustly validated, drug targets. Informed by industrial practice and concerns, the use of both biological and chemical tools in validation is key. In parallel, repurposing approved drugs for use as antimicrobials may provide both new treatments and identify new targets, whilst improved understanding of pharmacology will help develop and progress good 'hits' with the required rapidity. In recognition of the need to increase research efforts in these areas, in 14-16 September 2017, the British Society for Parasitology (BSP) Autumn Symposium was hosted at Durham University with the title: Microbial Protein Targets: towards understanding and intervention. Staged in collaboration with the Royal Society of Chemistry (RSC) Chemistry Biology Interface Division (CBID), the core aim was to bring together leading researchers working across disciplines to imagine novel approaches towards combating infection and antimicrobial resistance. Sessions were held on: 'Anti-infective discovery, an overview'; 'Omic approaches to target validation'; 'Genetic approaches to target validation'; 'Drug target structure and drug discovery'; 'Fragment-based approaches to drug discovery'; and 'Chemical approaches to target validation'. Here, we introduce a series of review and primary research articles from selected contributors to the Symposium, giving an overview of progress in understanding antimicrobial targets and developing new drugs. The Symposium was organized by Paul Denny (Durham) for the BSP and Patrick Steel (Durham) for RSC CBID.


Subject(s)
Anti-Infective Agents/pharmacology , Bacteria/drug effects , Drug Delivery Systems , Parasites/drug effects , Animals , Anti-Bacterial Agents/pharmacology , Bacteria/pathogenicity , Congresses as Topic , Drug Discovery , Parasites/pathogenicity , Research
9.
Parasitology ; 145(2): 219-236, 2018 02.
Article in English | MEDLINE | ID: mdl-28805165

ABSTRACT

Leishmaniasis is a vector-borne neglected tropical disease caused by protozoan parasites of the genus Leishmania for which there is a paucity of effective viable non-toxic drugs. There are 1·3 million new cases each year causing considerable socio-economic hardship, best measured in 2·4 million disability adjusted life years, with greatest impact on the poorest communities, which means that desperately needed new antileishmanial treatments have to be both affordable and accessible. Established medicines with cheaper and faster development times may hold the cure for this neglected tropical disease. This concept of using old drugs for new diseases may not be novel but, with the ambitious target of controlling or eradicating tropical diseases by 2020, this strategy is still an important one. In this review, we will explore the current state-of-the-art of drug repurposing strategies in the search for new treatments for leishmaniasis.


Subject(s)
Antiprotozoal Agents/pharmacology , Drug Discovery/methods , Drug Repositioning/methods , Animals , Antiprotozoal Agents/therapeutic use , Drug Discovery/trends , Humans , Leishmania/drug effects , Leishmaniasis/drug therapy , Neglected Diseases/drug therapy , Neglected Diseases/parasitology
10.
Postgrad Med J ; 94(1108): 97-103, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28866607

ABSTRACT

PURPOSE OF THE STUDY: There are few studies on the value of authoring questions as a study method, the quality of the questions produced by students and student perceptions of student-authored question banks. Here we evaluate PeerWise, a widely used and free online resource that allows students to author, answer and discuss multiple-choice questions. STUDY DESIGN: We introduced two undergraduate medical student cohorts to PeerWise (n=603). We looked at their patterns of PeerWise usage; identified associations between student engagement and summative exam performance; and used focus groups to assess student perceptions of the value of PeerWise for learning. We undertook item analysis to assess question difficulty and quality. RESULTS: Over two academic years, the two cohorts wrote 4671 questions, answered questions 606 658 times and posted 7735 comments. Question writing frequency correlated most strongly with summative performance (Spearman's rank: 0.24, p=<0.001). Student focus groups found that: (1) students valued curriculum specificity; and (2) students were concerned about student-authored question quality. Only two questions of the 300 'most-answered' questions analysed had an unacceptable discriminatory value (point-biserial correlation <0.2). CONCLUSIONS: Item analysis suggested acceptable question quality despite student concerns. Quantitative and qualitative methods indicated that PeerWise is a valuable study tool.


Subject(s)
Academic Performance/statistics & numerical data , Clinical Competence/standards , Education, Medical, Undergraduate/methods , Education, Medical, Undergraduate/standards , Educational Measurement/methods , Formative Feedback , Problem-Based Learning/standards , Students, Medical , Choice Behavior , Curriculum , Female , Focus Groups , Humans , Learning , Male , Peer Group , Reproducibility of Results , Teaching/standards
12.
Proc Natl Acad Sci U S A ; 110(6): E468-77, 2013 Feb 05.
Article in English | MEDLINE | ID: mdl-23329330

ABSTRACT

According to the Dobzhansky-Muller model, hybrid sterility is a consequence of the independent evolution of related taxa resulting in incompatible genomic interactions of their hybrids. The model implies that the incompatibilities evolve randomly, unless a particular gene or nongenic sequence diverges much faster than the rest of the genome. Here we propose that asynapsis of heterospecific chromosomes in meiotic prophase provides a recurrently evolving trigger for the meiotic arrest of interspecific F1 hybrids. We observed extensive asynapsis of chromosomes and disturbance of the sex body in >95% of pachynemas of Mus m. musculus × Mus m. domesticus sterile F1 males. Asynapsis was not preceded by a failure of double-strand break induction, and the rate of meiotic crossing over was not affected in synapsed chromosomes. DNA double-strand break repair was delayed or failed in unsynapsed autosomes, and misexpression of chromosome X and chromosome Y genes was detected in single pachynemas and by genome-wide expression profiling. Oocytes of F1 hybrid females showed the same kind of synaptic problems but with the incidence reduced to half. Most of the oocytes with pachytene asynapsis were eliminated before birth. We propose the heterospecific pairing of homologous chromosomes as a preexisting condition of asynapsis in interspecific hybrids. The asynapsis may represent a universal mechanistic basis of F1 hybrid sterility manifested by pachytene arrest. It is tempting to speculate that a fast-evolving subset of the noncoding genomic sequence important for chromosome pairing and synapsis may be the culprit.


Subject(s)
Infertility/genetics , Infertility/physiopathology , Mice, Inbred Strains/genetics , Mice, Inbred Strains/physiology , Animals , Apoptosis/genetics , Biological Evolution , Chromosome Pairing/genetics , Crosses, Genetic , DNA Breaks, Double-Stranded , Female , Genetic Speciation , Infertility/pathology , Male , Meiosis/genetics , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred Strains/classification , Models, Biological , Oocytes/pathology , Pregnancy , Recombination, Genetic , Species Specificity , Spermatocytes/pathology , Spermatogenesis/genetics , Transcriptome
14.
Int J Mol Sci ; 16(7): 15971-84, 2015 Jul 14.
Article in English | MEDLINE | ID: mdl-26184183

ABSTRACT

As part of the ongoing effort to functionally and structurally characterize virulence factors in the opportunistic pathogen Pseudomonas aeruginosa, we determined the crystal structure of YcaC co-purified with the target protein at resolutions of 2.34 and 2.56 Å without a priori knowledge of the protein identity or experimental phases. The three-dimensional structure of YcaC adopts a well-known cysteine hydrolase fold with the putative active site residues conserved. The active site cysteine is covalently bound to propionamide in one crystal form, whereas the second form contains an S-mercaptocysteine. The precise biological function of YcaC is unknown; however, related prokaryotic proteins have functions in antibacterial resistance, siderophore production and NADH biosynthesis. Here, we show that YcaC is exceptionally well conserved across both bacterial and fungal species despite being non-ubiquitous. This suggests that whilst YcaC may not be part of an integral pathway, the function could confer a significant evolutionary advantage to microbial life.


Subject(s)
Acrylamide/chemistry , Bacterial Proteins/chemistry , Hydrolases/chemistry , Pseudomonas aeruginosa/enzymology , Amino Acid Sequence , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Catalytic Domain , Crystallography, X-Ray , Hydrolases/genetics , Hydrolases/metabolism , Molecular Sequence Data , Protein Structure, Tertiary , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Sequence Alignment
15.
Molecules ; 20(2): 2775-85, 2015 Feb 06.
Article in English | MEDLINE | ID: mdl-25668079

ABSTRACT

Natural product antimicrobial peptides (AMPs) have been proposed as promising agents against the Leishmania species, insect vector borne protozoan parasites causing the neglected tropical disease leishmaniasis. However, recent studies have shown that the mammalian pathogenic amastigote form of L. mexicana, a causative agent of cutaneous leishmaniasis, is resistant to the amphibian-derived temporin family of AMPs when compared to the insect stage promastigote form. The mode of resistance is unknown, however the insect and mammalian stages of Leishmania possess radically different cell surface coats, with amastigotes displaying low (or zero) quantities of lipophosphoglycan (LPG) and proteophosphoglycan (PPG), macromolecules which form thick a glycocalyx in promastigotes. It has been predicted that negatively charged LPG and PPG influence the sensitivity/resistance of promastigote forms to cationic temporins. Using LPG and PPG mutant L. mexicana, and an extended range of temporins, in this study we demonstrated that whilst LPG has little role, PPG is a major factor in promastigote sensitivity to the temporin family of AMPs, possibly due to the conferred anionic charge. Therefore, the lack of PPG seen on the surface of pathogenic amastigote L. mexicana may be implicated in their resistance to these peptides.


Subject(s)
Antimicrobial Cationic Peptides , Leishmania mexicana/growth & development , Leishmaniasis, Cutaneous/drug therapy , Polysaccharides , Proteins , Antimicrobial Cationic Peptides/chemical synthesis , Antimicrobial Cationic Peptides/chemistry , Antimicrobial Cationic Peptides/pharmacology , Humans , Polysaccharides/chemistry , Polysaccharides/pharmacology , Proteins/chemical synthesis , Proteins/chemistry , Proteins/pharmacology
16.
Hum Mol Genet ; 21(8): 1706-24, 2012 Apr 15.
Article in English | MEDLINE | ID: mdl-22199023

ABSTRACT

Ariel is a mouse mutant that suffers from skeletal muscle myofibrillar degeneration due to the rapid accumulation of large intracellular protein aggregates. This fulminant disease is caused by an ENU-induced recessive mutation resulting in an L342Q change within the motor domain of the skeletal muscle myosin protein MYH4 (MyHC IIb). Although normal at birth, homozygous mice develop hindlimb paralysis from Day 13, consistent with the timing of the switch from developmental to adult myosin isoforms in mice. The mutated myosin (MYH4(L342Q)) is an aggregate-prone protein. Notwithstanding the speed of the process, biochemical analysis of purified aggregates showed the presence of proteins typically found in human myofibrillar myopathies, suggesting that the genesis of ariel aggregates follows a pathogenic pathway shared with other conformational protein diseases of skeletal muscle. In contrast, heterozygous mice are overtly and histologically indistinguishable from control mice. MYH4(L342Q) is present in muscles from heterozygous mice at only 7% of the levels of the wild-type protein, resulting in a small but significant increase in force production in isolated single fibres and indicating that elimination of the mutant protein in heterozygotes prevents the pathological changes observed in homozygotes. Recapitulation of the L342Q change in the functional equivalent of mouse MYH4 in human muscles, MYH1, results in a more aggregate-prone protein.


Subject(s)
Muscular Diseases/genetics , Myosin Heavy Chains/chemistry , Myosin Heavy Chains/genetics , Amino Acid Sequence , Animals , Genes, Recessive , Heterozygote , Homozygote , Humans , Mice , Molecular Sequence Data , Muscle, Skeletal/pathology , Muscular Diseases/metabolism , Muscular Diseases/pathology , Mutation , Myofibrils/ultrastructure , Myosin Heavy Chains/metabolism , Protein Conformation , Protein Structure, Tertiary , Transcription, Genetic
17.
PLoS Pathog ; 8(4): e1002660, 2012.
Article in English | MEDLINE | ID: mdl-22563306

ABSTRACT

Streptococcus pneumoniae is an important human pathogen responsible for a spectrum of diseases including pneumonia. Immunological and pro-inflammatory processes induced in the lung during pneumococcal infection are well documented, but little is known about the role played by immunoregulatory cells and cytokines in the control of such responses. We demonstrate considerable differences in the immunomodulatory cytokine transforming growth factor (TGF)-ß between the pneumococcal pneumonia resistant BALB/c and susceptible CBA/Ca mouse strains. Immunohistochemistry and flow cytometry reveal higher levels of TGF-ß protein in BALB/c lungs during pneumococcal pneumonia that correlates with a rapid rise in lung Foxp3(+)Helios(+) T regulatory cells. These cells have protective functions during pneumococcal pneumonia, because blocking their induction with an inhibitor of TGF-ß impairs BALB/c resistance to infection and aids bacterial dissemination from lungs. Conversely, adoptive transfer of T regulatory cells to CBA/Ca mice, prior to infection, prolongs survival and decreases bacterial dissemination from lungs to blood. Importantly, strong T regulatory cell responses also correlate with disease-resistance in outbred MF1 mice, confirming the importance of immunoregulatory cells in controlling protective responses to the pneumococcus. This study provides exciting new evidence for the importance of immunomodulation during pulmonary pneumococcal infection and suggests that TGF-ß signalling is a potential target for immunotherapy or drug design.


Subject(s)
Pneumonia, Pneumococcal/immunology , Signal Transduction/immunology , T-Lymphocytes, Regulatory/immunology , Transforming Growth Factor beta/immunology , Animals , DNA-Binding Proteins/immunology , Disease Susceptibility/immunology , Drug Delivery Systems , Female , Forkhead Transcription Factors/immunology , Mice , Mice, Inbred BALB C , Pneumonia, Pneumococcal/drug therapy , Species Specificity , Streptococcus pneumoniae/immunology , Transcription Factors/immunology , Transforming Growth Factor beta/antagonists & inhibitors
18.
AMB Express ; 14(1): 68, 2024 Jun 06.
Article in English | MEDLINE | ID: mdl-38844693

ABSTRACT

Toxoplasma gondii is an obligate intracellular parasite associated with severe disease, especially in the immunosuppressed. It is also a cause of congenital malformation and abortion in both animals and humans and is considered one of the most important foodborne pathogens worldwide with different strains showing variable distribution and differing pathogenicity. Thus, strain-level differentiation of T. gondii isolates is an essential asset in the understanding of parasite's diversity, geographical distribution, epidemiology and health risk. Here, we designed and implemented an Oxford Nanopore MinION protocol to analyse genomic sequence variation including single nucleotide polymorphisms (SNPs) and insertion/deletion polymorphisms (InDel's) of four different genomic loci, part of protein coding genes SAG2, SAG3, ROP17 and ROP21. This method provided results with the sequencing depth necessary for accurate differentiation of T. gondii strains and represents a rapid approach compared to conventional techniques which we further validated against environmental samples isolated from wild wood mice. In summary, multi-locus sequence typing (MLST) of both highly conserved and more polymorphic areas of the genome, provided robust data for strain classification in a platform ready for further adaption for other strains and pathogens.

19.
BMC Genomics ; 14: 242, 2013 Apr 11.
Article in English | MEDLINE | ID: mdl-23577770

ABSTRACT

BACKGROUND: Streptococcus pneumoniae causes over one million deaths worldwide annually, despite recent developments in vaccine and antibiotic therapy. Host susceptibility to pneumococcal infection and disease is controlled by a combination of genetic and environmental influences, but current knowledge remains limited. RESULTS: In order to identify novel host genetic variants as predictive risk factors or as potential targets for prophylaxis, we have looked for quantitative trait loci in a mouse model of invasive pneumococcal disease. We describe a novel locus, called Streptococcus pneumoniae infection resistance 2 (Spir2) on Chr4, which influences time to morbidity and the development of bacteraemia post-infection. CONCLUSIONS: The two quantitative trait loci we have identified (Spir1 and Spir2) are linked significantly to both bacteraemia and survival time. This may mean that the principle cause of death, in our model of pneumonia, is bacteraemia and the downstream inflammatory effects it precipitates in the host.


Subject(s)
Chromosomes, Mammalian , Genetic Predisposition to Disease , Microfilament Proteins/genetics , Pneumococcal Infections/genetics , Quantitative Trait Loci , Streptococcus pneumoniae , Animals , Bacteremia/genetics , Bacteremia/microbiology , Breeding , Female , Genotype , Haplotypes , Lod Score , Male , Mice , Phenotype , Pneumococcal Infections/microbiology , Pneumococcal Infections/mortality , Polymorphism, Single Nucleotide
20.
Org Biomol Chem ; 11(16): 2660-75, 2013 Apr 28.
Article in English | MEDLINE | ID: mdl-23467665

ABSTRACT

We recently reported the use of PSCl3 for the thiophosphorylation of alkylamines where the resulting N-thiophosphoramidate ions could be readily S-alkylated (Chem. Commun., 2011, 47, 6156-6158.). Herein we report the development of this methodology using amino acid, amino sugar, aminonucleoside and aniline substrates. The hydrolysis properties of N-thiophosphoramidate ions and their reactivities towards alkylating agents are also explored. In addition, we demonstrate the application of our approach to the preparation of a small library of compounds, including quinoline-based N,S-dialkylthiophosphoramidates which were tested for antileishmanial activity.


Subject(s)
Amides/chemistry , Amides/pharmacology , Antiprotozoal Agents/chemistry , Antiprotozoal Agents/pharmacology , Leishmania mexicana/drug effects , Phosphoric Acids/chemistry , Phosphoric Acids/pharmacology , Sulfhydryl Compounds/chemistry , Sulfhydryl Compounds/pharmacology , Acetamides/chemistry , Alkylating Agents/chemistry , Alkylation , Amides/chemical synthesis , Aniline Compounds/chemical synthesis , Aniline Compounds/chemistry , Antiprotozoal Agents/chemical synthesis , Deoxyadenosines/chemical synthesis , Deoxyadenosines/chemistry , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/chemical synthesis , Deoxyguanosine/chemistry , Glucosamine/chemical synthesis , Glucosamine/chemistry , Humans , Hydrolysis , Leishmaniasis, Cutaneous/drug therapy , Phenylalanine/chemical synthesis , Phenylalanine/chemistry , Phosphoric Acids/chemical synthesis , Phosphorylation , Sulfhydryl Compounds/chemical synthesis
SELECTION OF CITATIONS
SEARCH DETAIL